C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2006
08/17/2006	WO2006084728A2 Novel gene rcs 06
08/17/2006	WO2006084727A1 Gene rcs 05
08/17/2006	WO2006084726A1 Gene rcs 08
08/17/2006	WO2006084723A1 Gene sts 17
08/17/2006	WO2006084722A2 Gene sts 15
08/17/2006	WO2006084721A1 Alcohol dehydrogenase gene from gluconobacter oxydans
08/17/2006	WO2006084720A2 Hpr kinase from gluconobacter oxydan
08/17/2006	WO2006084719A1 Fermentive vitamin c production
08/17/2006	WO2006084718A1 Gene sms 12
08/17/2006	WO2006084717A1 Gene sms 02
08/17/2006	WO2006084716A1 Gene sms 14
08/17/2006	WO2006084715A1 Gene sms 13
08/17/2006	WO2006084713A2 Novel gene vcs 03
08/17/2006	WO2006084709A2 Novel gene sms 04
08/17/2006	WO2006084708A1 Gene sms 05
08/17/2006	WO2006084702A2 Novel gene sts 23
08/17/2006	WO2006084701A1 Phosphotransferase gene from gluconobacter oxydans
08/17/2006	WO2006084694A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition
08/17/2006	WO2006084664A1 Novel gene rcs 09
08/17/2006	WO2006084647A1 Gene vcs 01
08/17/2006	WO2006084644A2 Gene rcs 33
08/17/2006	WO2006084470A2 Enzymatic enantioselective ester or amide hydrolysis or synthesis
08/17/2006	WO2006084352A1 Novel omega-3 fatty acid desaturase family members and uses thereof
08/17/2006	WO2006046132A3 Method for modulating the evolution of a polypeptide encoded by a nucleic acid sequence
08/17/2006	WO2006042173A3 Modulators of hepatocyte growth factor activator
08/17/2006	WO2006037483A3 Alpha-amylase variants stabilized against dimerization and/or multimerization, method for the production thereof, and detergents and cleansers containing these alpha-amylase variants
08/17/2006	WO2006010930A3 Enzymes
08/17/2006	WO2006003461A3 Polypeptide
08/17/2006	WO2005114173A3 Hdm2-inhibitor complexes and uses thereof
08/17/2006	WO2005089514A3 Liquefaction processes
08/17/2006	WO2005065239A8 Novel recombinant proteins with n-terminal free thiol
08/17/2006	WO2005060722A3 Modulation of immune system function by modulation of polypeptide arginine methyltransferases
08/17/2006	WO2005046309A3 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
08/17/2006	WO2005028636A3 Novel cbh1 homologs and variant cbh1 cellulases
08/17/2006	WO2005007813A3 Novel phytase and gene
08/17/2006	US20060185038 Methods and means for increasing the tolerance of plants to stress conditions
08/17/2006	US20060185037 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
08/17/2006	US20060185036 Transgenic plants containing ligninase and cellulase which degrade lignin and cellulose to fermentable sugars
08/17/2006	US20060185035 Plant cellulose synthases
08/17/2006	US20060185032 Cytochrome P450 reductases from poppy plants
08/17/2006	US20060183895 Materials and methods for the modification of plant lignin content
08/17/2006	US20060183892 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids
08/17/2006	US20060183891 Delta 4,5 glycuronidase nucleic acid compositions
08/17/2006	US20060183715 Sulfated fucoglucuronomannan
08/17/2006	US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III
08/17/2006	US20060183695 Methods of increasing endogenous erythropoietin (EPO)
08/17/2006	US20060183688 Screening for drugs for treatment of pathologies involving deregulation of apoptosis including autoimmune diseases, neurological disorders and cancers
08/17/2006	US20060183687 Novel therapeutic molecules
08/17/2006	US20060183686 Thrombin-activatable fibrinolysis inhibitors (TAFI) enzyme molecules; inhibit the breakdown of blood clots, for use in treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease
08/17/2006	US20060183214 Modulation of plasma membrane Human Leukocyte Elastase
08/17/2006	US20060183213 Animal feed composition containing a thermotolerant phytase which retains at least 40% activity after 30 minutes at 60 degrees C. and has a specific activity of greater than 200 U/mg at pH 4.5 and 37 degrees C
08/17/2006	US20060183212 Thermostable luciferases and methods of production
08/17/2006	US20060183210 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
08/17/2006	US20060183209 Fusion protein for use in genration of preferential biopolymers in plants
08/17/2006	US20060183208 nanoscale solid support particles (e.g., fumed silica or alumina) having enzyme molecules electrostatically adhered thereto; for catalyzing reactions carried out in organic solvents
08/17/2006	US20060183207 Derived from Pyrococcus furious; structure-specific cleavage agents and polymerases for the cleavage and modification of nucleic acids
08/17/2006	US20060183202 Method for detoxification of mycotoxins
08/17/2006	US20060183196 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof
08/17/2006	US20060183188 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis
08/17/2006	US20060183168 Method for optimizing therapeutic efficacy of nemorubicin
08/17/2006	US20060183160 Novel beta-secretase and modulation of beta-secretase activity
08/17/2006	US20060183134 Nucleotide sequences coding mutY human homologue (MYH) gene for use as diagnostic tool in detection of colon cancer
08/17/2006	US20060183129 Isolated DNAs encoding the enzyme I-SpomI and its recognition and cutting site; useful in gene mapping and site-directed insertion of genes
08/17/2006	US20060183116 Identifying an inhibitor of cysteine glucosaminyl inositol ligase; drug screening; for treatment of actinomycete infections in mammals using antibiotics that inhibit production or activity of the enzymes of mycothiol biosynthesis, in particular MshC, MshD or MshA
08/17/2006	US20060182736 Transducible dna-binding proteins
08/17/2006	US20060182735 Thrombin preparations and process for their production
08/17/2006	US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors
08/17/2006	US20060182733 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means there for
08/17/2006	US20060182717 Vector for expressing alpha-N-acetyl-galactosaminidase and method of treating MPS I by stereotactic injection into the brain of a mammal
08/17/2006	CA2597499A1 Fermentive vitamin c production
08/17/2006	CA2597462A1 Novel microbial enzymes and their use
08/17/2006	CA2597225A1 Novel omega-3 fatty acid desaturase family members and uses thereof
08/17/2006	CA2595495A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/17/2006	CA2595395A1 Inhibiting her2 shedding with matrix metalloprotease antagonists
08/16/2006	EP1690945A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media
08/16/2006	EP1690944A1 Production of cellulase enzymes using the residues from ethanolic fermentation distillation of enzymatic hydrolysates from (ligno-)cellulosic materials
08/16/2006	EP1690535A2 Therapeutic use of nitric oxide precursor
08/16/2006	EP1690519A1 Alpha-glucosidase activity inhibitor
08/16/2006	EP1689888A2 Detection of mutations in a gene associated with resistance to viral infection, oas1
08/16/2006	EP1689877A1 Fusion proteins and methods of cleavage of such proteins
08/16/2006	EP1689876A1 L-threonine producing bacterium belonging to the genus escherichia and method for producing l-threonine
08/16/2006	EP1689873A2 Lactic acid producing yeast
08/16/2006	EP1689870A2 Improved targeted dna insertion in plants
08/16/2006	EP1689869A2 Recombinant microorganism
08/16/2006	EP1689862A2 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene
08/16/2006	EP1689861A1 Strain of rhodococcus rhodochrous ncimb 41164 and its use as producer of nitrile hydratase
08/16/2006	EP1689860A1 Process for preparing unsaturated amides and carboxil acids
08/16/2006	EP1689859A2 Perhydrolase
08/16/2006	EP1689776A2 Equine p-selectin glycoprotein ligand-1 and uses thereof
08/16/2006	EP1689766A1 Expression in filamentous fungi of protease inhibitors and variants thereof
08/16/2006	EP1689430A2 Tyrosinase mutant and methods of use thereof
08/16/2006	EP1601772A4 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
08/16/2006	EP1495112B1 Cell culture medium
08/16/2006	EP1397488B1 Novel compounds for chemiluminescense procedures
08/16/2006	EP1390477B1 Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases
08/16/2006	EP1309695B1 Polyketide synthases with altered specificity, their preparation and use
08/16/2006	EP1294920B1 Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same
08/16/2006	EP1263985B1 Methods for amplifying genetic material and uses thereof
08/16/2006	EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
08/16/2006	EP1064369B1 Nucleic acid binding proteins

1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1416